Profile data is unavailable for this security.
About the company
Fresenius SE & Co KGaA is a Germany-based healthcare company. The Company has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.
- Revenue in EUR (TTM)22.35bn
- Net income in EUR1.40bn
- Incorporated2011
- Employees177.36k
- LocationFresenius SE & Co KGaAElse-Kroener-Str. 1BAD HOMBURG 61352GermanyDEU
- Phone+49 61726080
- Websitehttps://www.fresenius.com/
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 13 Jun 2025 | 25.48m | 4.52% |
| Harris Associates LPas of 20 Aug 2024 | 16.85m | 2.99% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 15.43m | 2.74% |
| Capital International Ltd.as of 31 Dec 2025 | 13.69m | 2.43% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 10.77m | 1.91% |
| DWS Investment GmbHas of 08 Jan 2026 | 10.33m | 1.83% |
| BlackRock Fund Advisorsas of 09 Jan 2026 | 9.02m | 1.60% |
| Deka Investment GmbHas of 08 Jan 2026 | 8.72m | 1.55% |
| Union Investment Privatfonds GmbHas of 30 Nov 2025 | 6.06m | 1.08% |
| Geode Capital Management LLCas of 05 Feb 2026 | 5.84m | 1.04% |
